UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 560

Sortiert nach

Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment

Diabetes, obesity & metabolism, 2012-06, Vol.14 (6), p.546-554

2012

Link zum Volltext

Verfügbarkeit prüfen

Use of glucagon‐like peptide‐1 receptor agonists among individuals on basal insulin requiring treatment intensification

Diabetic medicine, 2018-06, Vol.35 (6), p.694-706

2018

Link zum Volltext

Verfügbarkeit prüfen

Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours

Gut, 1996-03, Vol.38 (3), p.430-438

1996

Link zum Volltext

Verfügbarkeit prüfen

Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes

Diabetic medicine, 2006-03, Vol.23 (3), p.240-245

2006

Link zum Volltext

Verfügbarkeit prüfen

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes

Diabetes, obesity & metabolism, 2006-07, Vol.8 (4), p.436-447

2006

Link zum Volltext

Verfügbarkeit prüfen

Prandial Glycaemia After a Carbohydrate-rich Meal in Type I Diabetic Patients: Using the Rapid Acting Insulin Analogue [Lys(B28), Pro(B29)] Human Insulin

Diabetic medicine, 1996-07, Vol.13 (7), p.625-629

1996

Link zum Volltext

Verfügbarkeit prüfen

Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes

Experimental and clinical endocrinology & diabetes, 1996, Vol.104 (1), p.25

1996

Link zum Volltext

Verfügbarkeit prüfen

Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure

Clinical therapeutics, 1999-10, Vol.21 (10), p.1703-1714

1999

Link zum Volltext

Verfügbarkeit prüfen

Effect of the Insulin Analogue [LYS(B28),PRO(B29)] on Blood Glucose Control

Hormone and metabolic research, 1994-12, Vol.26 (12), p.588-590

Trautmann, M. E.

1994

Link zum Volltext

Verfügbarkeit prüfen

Severe insulin resistance treated with insulin lispro

The Lancet (British edition), 1996-11, Vol.348 (9036), p.1248-1248

1996

Link zum Volltext

Verfügbarkeit prüfen

Alpha-subunit and human chorionic gonadotropin-β immunoreactivity in patients with malignant endocrine gastroenteropancreatic tumours

European journal of clinical investigation, 1994-02, Vol.24 (2), p.131-136

1994

Link zum Volltext

Verfügbarkeit prüfen

Synergistic stimulatory effect of glucagon-like peptide-1 (7–36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas

FEBS letters, 1989-07, Vol.252 (1), p.109-112

1989

Link zum Volltext

Verfügbarkeit prüfen

Postprandial treatment with Lispro insulin

Diabetes & metabolism, 1997-06, Vol.23 (3), p.232

1997

Link zum Volltext

Verfügbarkeit prüfen

Nucleolar organizer regions and glycoprotein-hormone α-chain reaction as markers of malignancy in endocrine tumours of the pancreas

Histopathology, 1993-01, Vol.22 (1), p.51-58

1993

Link zum Volltext

Verfügbarkeit prüfen

Preoperative localization of gastrointestinal endocrine tumors using somatostatin-receptor scintigraphy

Annals of surgery, 1993-11, Vol.218 (5), p.640-645

1993

Link zum Volltext

Verfügbarkeit prüfen

Gastroenteropancreatic endocrine tumors: Effect of Sandostatin ® on tumor growth

Metabolism, clinical and experimental, 1992-09, Vol.41 (9), p.116-118

1992

Link zum Volltext

Verfügbarkeit prüfen

Immunoreactivity and expression of amylin in gastroenteropancreatic endocrine tumors

The American journal of pathology, 1993-07, Vol.143 (1), p.283-291

1993

Link zum Volltext

Verfügbarkeit prüfen

Improved mealtime treatment of diabetes mellitus using an insulin analogue

Clinical therapeutics, 1997-01, Vol.19 (1), p.62-72

1997

Link zum Volltext

Verfügbarkeit prüfen

Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group

Diabetes (New York, N.Y.), 1997-02, Vol.46 (2), p.265

1997

Link zum Volltext

Verfügbarkeit prüfen

Signal transmission after GLP-1(7-36)amide binding in RINm5F cells

American journal of physiology: Gastrointestinal and liver physiology, 1989-09, Vol.257 (3 Pt 1), p.G397-G401

1989

Link zum Volltext

Verfügbarkeit prüfen

Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: A multinational, randomized, open-label, two-period, crossover noninferiority trial

Clinical therapeutics, 2007-11, Vol.29 (11), p.2333-2348

2007

Link zum Volltext

Verfügbarkeit prüfen

Interaction of glucagon-like peptide-1 (7-36)amide and cholecystokinin-8 in the endocrine and exocrine rat pancreas

Pancreas, 1990-05, Vol.5 (3), p.361-365

1990

Link zum Volltext

Verfügbarkeit prüfen

Sodium butyrate induces neuroendocrine cytodifferentiation in the insulinoma cell line RINm5F

Pancreas, 1994-07, Vol.9 (4), p.460-468

1994

Link zum Volltext

Verfügbarkeit prüfen

Early Pharmacodynamic Effects of Exenatide Once Weekly in Type 2 Diabetes Are Independent of Weight Loss: A Pooled Analysis of Patient-Level Data

Clinical therapeutics, 2016-06, Vol.38 (6), p.1464-1473

2016

Link zum Volltext

Verfügbarkeit prüfen

Characterization of glucose transport in an insulin-secreting cell line

Biochemical journal, 1987-03, Vol.242 (3), p.625-630

1987

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 560

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(457)
Mit Volltextzugriff
(497)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment

Use of glucagon‐like peptide‐1 receptor agonists among individuals on basal insulin requiring treatment intensification

Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours

Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes

Prandial Glycaemia After a Carbohydrate-rich Meal in Type I Diabetic Patients: Using the Rapid Acting Insulin Analogue [Lys(B28), Pro(B29)] Human Insulin

Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes

Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure

Effect of the Insulin Analogue [LYS(B28),PRO(B29)] on Blood Glucose Control

Severe insulin resistance treated with insulin lispro

Alpha-subunit and human chorionic gonadotropin-β immunoreactivity in patients with malignant endocrine gastroenteropancreatic tumours

Synergistic stimulatory effect of glucagon-like peptide-1 (7–36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas

Postprandial treatment with Lispro insulin

Nucleolar organizer regions and glycoprotein-hormone α-chain reaction as markers of malignancy in endocrine tumours of the pancreas

Preoperative localization of gastrointestinal endocrine tumors using somatostatin-receptor scintigraphy

Gastroenteropancreatic endocrine tumors: Effect of Sandostatin ® on tumor growth

Immunoreactivity and expression of amylin in gastroenteropancreatic endocrine tumors

Improved mealtime treatment of diabetes mellitus using an insulin analogue

Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group

Signal transmission after GLP-1(7-36)amide binding in RINm5F cells

Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: A multinational, randomized, open-label, two-period, crossover noninferiority trial

Interaction of glucagon-like peptide-1 (7-36)amide and cholecystokinin-8 in the endocrine and exocrine rat pancreas

Sodium butyrate induces neuroendocrine cytodifferentiation in the insulinoma cell line RINm5F

Early Pharmacodynamic Effects of Exenatide Once Weekly in Type 2 Diabetes Are Independent of Weight Loss: A Pooled Analysis of Patient-Level Data

Characterization of glucose transport in an insulin-secreting cell line

Suchergebnisse filtern